This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Cannabis science is a growing field, but People Science thinks it can be done on a wider, more collective scale, so it’s bringing the research tools right to your phone. The datacollected will be sent to People Science, along with the responses from a short daily questionnaire. Register now. How the study works.
CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. While CBN is often marketed as “the sleep cannabinoid ,” the reality is more complicated.
While animal studies have revealed that cannabinoid receptors likely have a role in modulating auditory signaling, there is no compelling data either from animal or human studies for the use of cannabinoids to alleviate tinnitus.” While the collective evidence to date is mixed and inconclusive, it’s also incomplete.
The combination of minor cannabinoids THCV and CBG could help reduce bad eating habits like snacking and late-night binge eating, according to real-world data (RWD) collected from Cannigma readers last month. But the decrease in appetite is not just seen in the data – it’s also part of the lived experience.
When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. EG: Right, yeah.
But newer research, including from this year, has indicated that cannabinoid suppositories do have clinical utility, and real-world datacollected recently from Cannigma users shows that a CBD product based on a full extract cannabis oil (FECO) can significantly improve menstrual symptoms. And she got what she was looking for!
The research findings of the study, entitled “A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health,” was published this week in the journal Cannabis and Cannabinoid Research , Volume X, Number X, 2020. Study Findings.
Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced datacollection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands.
The new Cultivar Collection from Trulieve demonstrates how a multi-state player can stay craft at its core. Breeders must painstakingly identify and select ideal combinations of cannabinoids and terpenes, while cultivators carry the torch, ensuring that the chosen genetics grow into consistently perfect and utterly maximized flowers. .
Despite being touted as a wonder drug, CBD doesn’t work for everyone, and many clinicians are now leaning into other cannabinoids. And along with research, real-world data can help us understand how topical products infused with minor cannabinoids could help with various aches and pains.
Many people think that losing terpenes is a good trade for acquiring the cannabinoids but the terpene content responsible for the flavors and aromas associated with cannabis. The team of researchers at Eybna Technologies collected the data concerning the plant’s terpene profile through the use of their proprietary Headspace technology.
This study analyzes the components of vaporizer cartridges for 10 different metals and also collects aerosol mixtures from 13 randomly purchased commercially available cannabis cartridges from Washington State to compare their elemental profiles. Supporting Information. The Supporting Information is available free of charge at [link].
Last week, the Food Standard Agency (“ FSA ”), the agency responsible for protecting public health in relation to food in England, Wales and Northern Ireland (collectively, the “UK”), cleared a path for the sale of CBD-infused food for the next 12 months. The EFSA guidance on cannabinoids strongly echoes the U.S.
Descriptive Research: This type of research aims to do exactly what the name suggests, to describe and define the characteristics of the subject matter, such as cannabinoids, terpenes, and other compounds. . Non-Experimental Research: Observational study, or non-experimental research, focuses on analyzing data in its natural context.
In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s datacollection needs. Furthermore, THC and CBD may have a synergistic effect.
Our most recent data shows how cannabinoids via industrial hemp decreased the stress hormone cortisol as well as the inflammatory biomarker prostaglandin E2. He adds, “The initial data we have collected is essential should industrial hemp and its by-product be considered by the U.S. milligrams CBDA daily.
Technology-enabled clinical research company People Science is carrying out a study into the effects of cannabinoids on sleep behavior. million, People Science plans to invest in ongoing R&D on cannabis, cannabinoids, the microbiome, psychedelics, and digital health interventions. The company is now sitting on $8.5
Some researchers believe that cannabinoids may help people with ASD manage anxiety and stress by increasing their ability to focus and pay attention. collecting items related to trains). Cannabinoids have been shown to help people with autism manage anxiety and stress.
Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.
Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. Of course, legalization and education efforts can only go so far without data, and that’s where RoC’s research initiatives come into play.
Food and Drug Administration (“FDA”), recently changed guidance on cannabinoids, declaring that all new food products infused with the plant or its derivatives should receive a pre-market approval under the European Union “novel food” regulation. This also applies to extracts of other plants containing cannabinoids.
These regulatory bodies work in conjunction with each other, and collectively share the responsibility of overseeing cannabis regulation across Canada. Regulatory Authorities share the collective responsibility of enforcement and compliance. Use of Non-controlled Cannabinoids in Food. Enforcement.
Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.
The study will utilize Radicle Science’s data analytics platform and a virtual, direct-to-consumer model to deliver objective health outcome data across diverse populations and conditions. This randomized controlled trial will collectdata on 13 U.S. Nutritional Outlook.
Kassi is equipped for advanced datacollection, offering accurate, real-time, shareable dispensing history, automated reminders and personal recommendations. DSI’s unique vapor platform is the most effective and safest cannabinoid inhalation delivery method available today.
It is a synthetic cannabinoid that produces psychedelic effects to its users. THC-O is not an entirely natural cannabinoid. It’s one of many synthetic cannabinoids and does not occur on its own without human intervention. THC-O is also new to the market and does not have any long-term data. About THC-O. THC-O Gummies.
Do you think that most patients viewed cannabinoid-based therapeutics as an effective pain remedy? A June 2022 research study conducted in Ontario Canada (where cannabis-based medicine is legal at the federal level), assessed how chronic pain patients view the use of cannabis-based products for medicinal purposes.
About InMed: InMed Pharmaceuticals is a clinical stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. For more information, visit www.inmedpharma.com. For more information, visit www.inmedpharma.com.
For this new study, the researchers used data from 28 cannabis genomes already publicly available in the literature. In addition to looking at the demographic history of these sample strains, the researchers also carried out a closer examination on the function of the two main cannabinoid synthase genes – CBDAS and THCAS – in these samples.
For the time being, and thanks to the onset of a new era of cannabis legalization, thousands of studies on cannabis and cannabinoids are published each year by the scientific community. Today, there is an enormous quantity and varied quality of scientific data, and this study is a fundamental tool that optimizes the way we access it.
Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant. Some concerns include variability in product formulations and product labeling, other cannabinoid and terpene content, and variable delta-8 THC concentrations. synthetic conversion).
As we collectively analyze and respond to emerging issues in the cannabis industry, we will continue to be the preeminent voice in cannabis regulatory policy.”. Public Health and Data Monitoring. Cannabinoid Hemp. Social and Economic Equity. Medical Use and Research. Lab Testing and Product Safety. Public Education.
Data were collected at three different time points: baseline, 4, and 8 weeks. Cannabinoids, and specifically Cannabidiol, is proposed as an opioid alternative, having comparable efficacy with better safety profile. Data were collected at three different time points: baseline, 4, and 8 weeks.
The team of researchers analyzed data from nearly 20,000 people over a four-year period and found that cannabis use among cancer patients peaked at 9%. ” The researchers from VCU make use of datacollected from the Population Assessment of Tobacco and Health (PATH), which tracked tobacco AND cannabis smoking behaviors.
The research team compiled the study by extracting archival data from Reddit’s open source application programming interface between 2008-2018. Veterans collectively discussed how the use of medical marijuana reduced PTSD symptoms, feelings of anxiety, and helped them sleep better.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.
The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. THC is a naturally occurring cannabinoid produced by the cannabis plant. million individuals in the U.S.
NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,
A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. Data CEO Julie Armstrong said her company knows the COVID-19 affects the population in a similar way to influenza.
and sold and owned by CV and managed by Shanti include but are not limited to application patents, intellectual property, formulae, compounds, solutions, research, data, techniques, processes, brand names, trade names, trademarks. The Deal: The assets acquired by Global Wellness Strategies Inc. The purchase price of CDN$2,500,000.00
The 14-page document covers several aspects of the drug development process, including trial best practices, datacollection, and new drug application requirements. The basis of the CSMAS argument stems from the findings of the 2022 Summit on Cannabinoids in College Athletics.
million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). For example, rather than having researchers carry out a controlled investigation, each study subject provided self-reported data.
mg total cannabinoids. Researchers analyzed the data self-reported by the 18 participants and found statistically significant differences (which adds power and confidence to the results) between the experimental conditions in many of the items and scales used. CBD alters the subjective effects of THC.
What scientists do recognize is that cannabinoids act with the endocannabinoid receptors situated within the body. According to experts, CBD is used due to its healing properties, though there’s no conclusive data on this use. After years of collecting information from hundreds of cannabis experts and institution.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content